Search Results 291-300 of 18003 for Alopecia

1. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

   ... alopecia - Patients who are receiving any other investigational agents - Patients with uncontrolled intercurrent illness - Patients who cannot discontinue ...

2. Publications - Amjad N. Kanj, M.D., M.P.H. - Mayo Clinic

   Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women. Open Forum Infect Dis. 2019 Jul; 6(7):ofz278. Epub 2019 Jun 06. View PubMed ...

3. Phase III Study Of Rilvegostomig In Combination With Bevacizumab With Or Without Tremelimumab As First-line Treatment Of Hepatocellular Carcinoma - Mayo Clinic

   * Persistent toxicities caused by previous anti-cancer therapy excluding alopecia, not yet improved to Grade ≤ 1 or baseline. * Clinically meaningful ...

4. Valchlor in the Treatment of Lichen Planopilaris - Mayo Clinic

   Biopsy proven diagnosis of Fontal Fibrosing Alopecia (a clinical variant of LPP restricted to frontal scalp); Good general health as confirmed by medical ...

5. Clinical trials - Oncology (Medical)

   Natural History Evaluation Among Female Breast Cancer Survivors with Endocrine Therapy-Induced Alopecia. Rochester, Minn., Mankato, Minn., Albert Lea, Minn ...

6. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

   - All grades of alopecia are acceptable - Endocrine dysfunction on replacement therapy is acceptable - Severe or unstable medical condition, including ...

7. Head and neck cancers - Doctors and departments - Mayo Clinic

   ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...

8. First in Human Study of TORL-4-500 in Participants With Advanced Cancer - Mayo Clinic

   ... alopecia or laboratory abnormalities otherwise meeting eligibility requirements * Received prior chemotherapeutic, investigational, or other therapies for ...

9. Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors - Mayo Clinic

   ... alopecia, bone marrow and organ functions); Patient has impairment of gastrointestinal (GI) function or GI disease that may significantly alter the ...

10. A Study of a Personalized Neoantigen Cancer Vaccine - Mayo Clinic

    ... alopecia, and hypothyroidism that is controlled with hormone replacement therapy). Active, known, or suspected autoimmune disease. Note: Patients with type ...